AR058735A1 - Composiciones farmaceuticas que contienen la proteina nma 0939 - Google Patents
Composiciones farmaceuticas que contienen la proteina nma 0939Info
- Publication number
- AR058735A1 AR058735A1 ARP060105777A ARP060105777A AR058735A1 AR 058735 A1 AR058735 A1 AR 058735A1 AR P060105777 A ARP060105777 A AR P060105777A AR P060105777 A ARP060105777 A AR P060105777A AR 058735 A1 AR058735 A1 AR 058735A1
- Authority
- AR
- Argentina
- Prior art keywords
- nma0939
- protein
- compositions
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Composiciones farmacéuticas que contienen la proteína NMA0939. Las composiciones confieren proteccion contra diferentes enfermedades, causadas o no por patogenos. LA proteína NMA0939 se identifico como componente de las preparaciones de vesículas de membrana externa de Neisseria meningitidis, se obtuvo mediante la tecnología del ADN recombinante y se evaluo su inmunogenicidad y actividad protectora en modelos animales. Por el elevado grado de conservacion del gen que codifica para la proteína NMA0939, las composiciones que la contienen poseen alto valor como antígeno inductor de una respuesta inmune de amplia reactividad. Las composiciones son aplicables en la medicina humana.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20050279A CU23549A1 (es) | 2005-12-29 | 2005-12-29 | Composiciones farmacéuticas que contienen la proteína nma0939 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR058735A1 true AR058735A1 (es) | 2008-02-20 |
Family
ID=38218331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060105777A AR058735A1 (es) | 2005-12-29 | 2006-12-26 | Composiciones farmaceuticas que contienen la proteina nma 0939 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090208521A1 (es) |
| EP (1) | EP1977761A2 (es) |
| KR (1) | KR20080081198A (es) |
| CN (1) | CN101443037A (es) |
| AR (1) | AR058735A1 (es) |
| AU (1) | AU2006331224A1 (es) |
| BR (1) | BRPI0620867A2 (es) |
| CA (1) | CA2633424A1 (es) |
| CU (1) | CU23549A1 (es) |
| NO (1) | NO20083318L (es) |
| RU (1) | RU2008131066A (es) |
| WO (1) | WO2007073705A2 (es) |
| ZA (1) | ZA200805355B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018042017A2 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60042114D1 (de) * | 1999-04-30 | 2009-06-10 | Craig J Venter Inst Inc | Genomische sequenzen von neisseria und verfahren zu ihrer verwendung |
| GB0103424D0 (en) * | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
| JP4740738B2 (ja) * | 2002-08-02 | 2011-08-03 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| CU23236A1 (es) * | 2003-12-03 | 2007-09-26 | Ct Ingenieria Genetica Biotech | PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P |
-
2005
- 2005-12-29 CU CU20050279A patent/CU23549A1/es active IP Right Grant
-
2006
- 2006-12-26 AR ARP060105777A patent/AR058735A1/es unknown
- 2006-12-28 CA CA002633424A patent/CA2633424A1/en not_active Abandoned
- 2006-12-28 EP EP06846929A patent/EP1977761A2/en not_active Withdrawn
- 2006-12-28 RU RU2008131066/13A patent/RU2008131066A/ru not_active Application Discontinuation
- 2006-12-28 WO PCT/CU2006/000019 patent/WO2007073705A2/es not_active Ceased
- 2006-12-28 CN CNA200680049521XA patent/CN101443037A/zh active Pending
- 2006-12-28 AU AU2006331224A patent/AU2006331224A1/en not_active Abandoned
- 2006-12-28 BR BRPI0620867-3A patent/BRPI0620867A2/pt not_active IP Right Cessation
- 2006-12-28 US US12/097,895 patent/US20090208521A1/en not_active Abandoned
- 2006-12-28 KR KR1020087018520A patent/KR20080081198A/ko not_active Withdrawn
-
2008
- 2008-06-19 ZA ZA200805355A patent/ZA200805355B/xx unknown
- 2008-07-28 NO NO20083318A patent/NO20083318L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20083318L (no) | 2008-09-26 |
| AU2006331224A1 (en) | 2007-07-05 |
| KR20080081198A (ko) | 2008-09-08 |
| WO2007073705A2 (es) | 2007-07-05 |
| CA2633424A1 (en) | 2007-07-05 |
| CU23549A1 (es) | 2010-07-20 |
| CN101443037A (zh) | 2009-05-27 |
| BRPI0620867A2 (pt) | 2011-11-29 |
| EP1977761A2 (en) | 2008-10-08 |
| RU2008131066A (ru) | 2010-02-10 |
| WO2007073705A3 (es) | 2007-09-13 |
| CU23549B7 (es) | 2010-07-20 |
| ZA200805355B (en) | 2009-04-29 |
| US20090208521A1 (en) | 2009-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| CY1118373T1 (el) | Υψηλης συγκεντρωσης υγρες μορφοποιησεις anti-tnfa αντισωματος | |
| MX2019005268A (es) | Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer. | |
| EA200601671A1 (ru) | Идентификация собственных и чужеродных антигенов, вовлечённых в аутоиммунные заболевания | |
| BRPI0416796A (pt) | compostos orgánicos | |
| MX349481B (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. | |
| NZ601538A (en) | Vaccine compositions comprising a mutated factor h binding protein | |
| WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
| WO2007022425A3 (en) | Influenza recombinant subunit vaccine | |
| GEP201706766B (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
| CY1113693T1 (el) | Φαρμακευτικες συνθεσεις και μεθοδοι για τον εμβολιασμο κατα της διαχυτης καντιντιασης και αλλων μολυσματικων παραγοντων | |
| ATE461710T1 (de) | Nipah-virus-impfstoffe | |
| EP1556513A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES MEDIATED BY THE HUMANE PAPILLOMA VIRUS | |
| AR060797A1 (es) | Composicion farmaceutica que comprende la proteina nmb0606 | |
| AR058735A1 (es) | Composiciones farmaceuticas que contienen la proteina nma 0939 | |
| AR060796A1 (es) | Composicion farmaceutica que comprende la proteina nmb0938 | |
| BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo | |
| WO2009077744A3 (en) | Vaccines for brucellosis | |
| CU23528A1 (es) | Composición farmacéutica que comprende la proteína nmb0848 | |
| CU23584A1 (es) | Composición farmacéutica que comprende la proteína nmb1796 | |
| AR046937A1 (es) | Proteina nmb0928 y su uso en formulaciones farmaceuticas | |
| WO2007008904A3 (en) | Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections | |
| AR047263A1 (es) | Proteina nmb1125 y su uso en formulaciones farmaceuticas | |
| ATE495757T1 (de) | Attenuierte bakterielle lebendvakzine | |
| AR069647A1 (es) | Composicion farmaceutica que comprende la proteina nmb 0873 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |